MARKET ACCESS & PRICING

 

 

Market Access & Pricing, Tuesday 31 March 2020

Anand Jha
Market Access & Pricing
11:30

Moving from market access to patient access from a payer's perspective

Anand Jha, Managing Director, Ansea Consultants Pte Ltd
Market Access & Pricing
11:50

Improving patient access to new drugs: The South Korea perspective

Pritha Aggarwal
Market Access & Pricing
12:10

Making antibodies affordable for all

Panel discussion
14:00

Innovating drug discovery with blockchain & machine learning

Finny Liu
Market Access & Pricing
15:40

Panel: Real world evidence - Driving a new drug development paradigm

Market Access & Pricing
16:20

Importance of collecting sufficient clinical and economic evidence during clinical development phase

Market Access & Pricing
16:40

Overcoming challenges in determining customer value for value-based pricing

Market Access & Pricing
17:00

Using value-based strategy in Europe to increase patient access to drugs - Valuable lessons for Asia

Market Access & Pricing
17:20

Takeda: A step closer to implementing value-based pricing in Asia

last published: 13/Nov/19 01:25

Market Access & Pricing, Wednesday 1 April 2020

Market Access & Pricing
14:00

Driving adoption of HEOR in the decision process: Lessons for Asia

Market Access & Pricing
14:20

Using data to understand how drugs are being used and improve access

Market Access & Pricing
14:40

Providing optimal health outcomes for patients without bankrupting the system

Market Access & Pricing
15:00

Forming a collaborative relationship with stakeholders and payers

Market Access & Pricing
15:20

Panel: Treating stakeholders and payers like customers

last published: 13/Nov/19 01:25

 

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738